doc_id,table_id,row_index,ColumnA,ColumnB,ColumnC
WHO_TB_handbook_module5_pediatrics_2022,Table 5.13.,1,Medicine,CSF penetration,
WHO_TB_handbook_module5_pediatrics_2022,Table 5.13.,2,"Levofloxacin, moxifloxacin, linezolid, cycloserine, ethionamide, meropenem, pyrazinamide",Good penetration,
WHO_TB_handbook_module5_pediatrics_2022,Table 5.13.,3,"Isoniazid in presence of isoniazid resistance, P-aminosalicylic acid, amikacin","Poor penetration, except in presence of meningeal inflammation",
WHO_TB_handbook_module5_pediatrics_2022,Table 5.13.,4,Ethambutol,Poor penetration,
WHO_TB_handbook_module5_pediatrics_2022,Table 5.13.,5,"Bedaquiline, delamanid, clofazimine",Limited data available,